SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-06-025448
Filing Date
2006-04-17
Accepted
2006-04-17 16:06:21
Documents
8
Period of Report
2006-05-17
Effectiveness Date
2006-04-17

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT a06-3259_2def14a.htm DEF 14A 916170
2 GRAPHIC g32592bci001.gif GRAPHIC 3097
3 GRAPHIC g32592bci002.gif GRAPHIC 2852
4 GRAPHIC g32592jai001.gif GRAPHIC 3097
5 GRAPHIC g32592jai002.gif GRAPHIC 9488
6 GRAPHIC g32592dwi001.gif GRAPHIC 22699
7 GRAPHIC g32592dwi002.gif GRAPHIC 2852
8 GRAPHIC g32592bei001.gif GRAPHIC 2852
  Complete submission text file 0001104659-06-025448.txt   983344
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19700 | Film No.: 06762453
SIC: 2834 Pharmaceutical Preparations